Trial Profile
A 4-year Research Study to Demonstrate Value of PET Scans In Alzheimer's Disease Diagnosis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 23 Oct 2019
Price :
$35
*
At a glance
- Drugs Florbetaben F18 (Primary) ; Florbetapir F 18 (Primary) ; Flutemetamol-F-18 (Primary)
- Indications Alzheimer's disease
- Focus Diagnostic use
- Acronyms IDEAS
- 27 Mar 2019 According to a Life Molecular Imaging, Piramal imaging changed its name to Life Molecular Imaging.
- 19 Jul 2017 According to a Piramal Imaging media release, results from the first 3979 participants have been presented at at the 2017 Alzheimer's Association International Conference (AAIC 2017).
- 19 Jul 2017 Interim results published in the Alzheimer's Association media release.